Furthermore, the evaluation of BACH1 post-translational modifications revealed that BACH1 mono-ubiquitinylation levels were reduced only in DS, while increased levels of BACH1 poly-ubiquitinylation were observed only in DSAD subjects [6]. The gene discussed is BACH1; the disease is Dravet syndrome.